SCHEMBL20535148

SCHEMBL20535148

CC(C)(CCC(=O)O)c1cc(F)ccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 3/20 0.43
TBXA2R P21731 2/20 0.41
RBP4 P02753 1/20 0.40
ALDH1A1 P00352 1/20 0.37
ESR1 P03372 1/20 0.37
CYP3A4 P08684 1/20 0.37
ESR2 Q92731 1/20 0.37
NR3C1 P04150 2/20 0.36
NR3C2 P08235 2/20 0.36
CHEK1 O14757 1/20 0.35
FYN P06241 1/20 0.35
PDGFRB P09619 1/20 0.35
PIM1 P11309 1/20 0.35
FGFR1 P11362 1/20 0.35
FLT1 P17948 1/20 0.35
GRK5 P34947 1/20 0.35
MAP2K2 P36507 1/20 0.35
MAPK8 P45983 1/20 0.35
CDK8 P49336 1/20 0.35
RPS6KA3 P51812 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21632116 0.83 PTGFR (0.46) PTGFRTBXA2RRBP4ALDH1A1ESR1
SCHEMBL21631911 0.82 PTGFR (0.40) PTGFRTBXA2RRBP4ALDH1A1ESR1
SCHEMBL30838760 0.81 KCNN4 (0.44) TBXA2RRBP4ALDH1A1ESR1CYP3A4
SCHEMBL4826451 0.79 ERCC5 (0.39) TBXA2RNR3C1NR3C2ANO1
SCHEMBL20535152 0.78 HTR2A (0.42) PTGFRALDH1A1ESR1CYP3A4ESR2
SCHEMBL5643833 0.73 FFAR1 (0.43) TBXA2RRBP4ALDH1A1ESR1CYP3A4
SCHEMBL803635 0.70 PTGS1 (0.39) NR3C1NR3C2CYP2C9HIF1A
SCHEMBL5644509 0.70 FFAR1 (0.40) PTGFRTBXA2RRBP4ALDH1A1ESR1
SCHEMBL5427170 0.69 FFAR1 (0.49) TBXA2RALDH1A1CYP3A4MAPK1CYP2C9
Carbamic Acid SCHEMBL11788382 0.69 HTR3E (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed